Selected Publication:
Bochkov, VN; Mechtcheriakova, D; Lucerna, M; Huber, J; Malli, R; Graier, WF; Hofer, E; Binder, BR; Leitinger, N. 
Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.
Blood. 2002; 99(1):199-206
 Doi: 10.1182/blood.V99.1.199
 [OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
 
- Co-authors Med Uni Graz
 
- 
Graier Wolfgang
 
- 
Malli Roland
 
-  Altmetrics: 
 
-  Dimensions Citations: 
 
-  Plum Analytics: 
 
-  Scite (citation analytics): 
 
- Abstract:
 
- Activation of endothelial cells by lipid oxidation products is a key event in the initiation and progression of the atherosclerotic lesion. Minimally modified low-density lipoprotein (MM-LDL) induces the expression of certain inflammatory molecules such as tissue factor (TF) in endothelial cells. This study examined intracellular signaling pathways leading to TF up-regulation by oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC), a biologically active component of MM-LDL. OxPAPC induced TF activity and protein expression in human umbilical vein endothelial cells (HUVECs). However, OxPAPC neither induced phosphorylation or degradation of I kappa B alpha nor DNA binding of nuclear factor-kappa B (NF-kappa B). Furthermore, OxPAPC-induced TF expression was not inhibited by overexpression of I kappa B alpha. These results strongly indicate that OxPAPC-induced TF expression is independent of the classical NF-kappa B pathway. However, OxPAPC stimulated phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and expression of early growth response factor 1 (EGR-1). Inhibitors of mitogen-activated kinase/ERK (MEK) or protein kinase C (PKC) blocked elevation of both EGR-1 and TF. Furthermore, overexpression of NAB2, a corepressor of EGR-1, inhibited effects of OxPAPC. In addition, OxPAPC induced rapid and reversible elevation of free cytosolic Ca(++) levels and nuclear factor of activated T cells (NFAT)/DNA binding. Induction of TF expression by OxPAPC was partially inhibited by cyclosporin A, known to block calcineurin, a Ca(++)-dependent phosphatase upstream of NFAT. Treatment of OxPAPC with phospholipase A(2) destroyed its biologic activity and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine was identified as one biologically active component of OxPAPC that induces TF expression. Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription. Thus, oxidized phospholipids may contribute to inflammation by activating pathways alternative to the classical NF-kappa B pathway.
 
- Find related publications in this database (using NLM MeSH Indexing)
 
- 
Calcineurin - antagonists and inhibitors 
 
- 
Calcium - metabolism 
 
- 
Cells, Cultured - metabolism 
 
- 
Cyclosporine - pharmacology 
 
- 
DNA - metabolism 
 
- 
DNA-Binding Proteins - metabolism 
 
- 
Early Growth Response Protein 1 - metabolism 
 
- 
Endothelium, Vascular - drug effects 
 
- 
Enzyme Activation - drug effects 
 
- 
Humans - drug effects 
 
- 
I-kappa B Proteins - drug effects 
 
- 
Immediate-Early Proteins - drug effects 
 
- 
Mitogen-Activated Protein Kinase 1 - metabolism 
 
- 
Mitogen-Activated Protein Kinase 3 - metabolism 
 
- 
Mitogen-Activated Protein Kinases - metabolism 
 
- 
NF-kappa B - metabolism 
 
- 
NFATC Transcription Factors - metabolism 
 
- 
Nuclear Proteins - metabolism 
 
- 
Oxidation-Reduction - metabolism 
 
- 
Phospholipases A - pharmacology 
 
- 
Phospholipid Ethers - pharmacology 
 
- 
Phosphorylation - pharmacology 
 
- 
Thromboplastin - metabolism 
 
- 
Transcription Factors - metabolism 
 
- 
Umbilical Veins - metabolism